Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Xenon Pharmaceuticals IncfiledCriticalNovartis Ag
Priority to CU20120052ApriorityCriticalpatent/CU20120052A7/en
Publication of CU20120052A7publicationCriticalpatent/CU20120052A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona derivados heterocíclicos que modulan la actividad de la estearoil-CoA-desaturasa. También se abarcan los métodos para utilizar estos derivados con el fin de modular la actividad de la estearoil-CoA-desaturasa, y las composiciones farmacéuticas que comprenden estos derivados.The present invention provides heterocyclic derivatives that modulate the activity of stearoyl-CoA desaturase. Methods for using these derivatives are also covered in order to modulate the activity of stearoyl-CoA desaturase, and pharmaceutical compositions comprising these derivatives.
CU20120052A2012-03-292012-03-29
PIRAZOL DERIVATIVES THAT MODULATE ESTEAROIL-COA-DESATURASA
CU20120052A7
(en)